Date Posted: March 19, 2012
Summary: Copy of presentation given by Xceleron’s CSO, Dr Graham Lappin, at the 2012 ASCPT meeting, held at the Gaylord National Hotel & Convention Center, National Harbor, Maryland from 12 – 17th March Presentation Date: 17th March, 2012 Presenters / Speakers This talk was given as part of a workshop called “Metabolites in Safety Testing:Continue Reading
Date Posted: February 29, 2012
Summary: This is a copy of a presentation given by Xceleron CSO, Professor Graham Lappin, at the 2nd Annual Biologics Symposium, Cambridge, UK Presentation Date: 28th February 2012 Presenters / Speakers Professor Graham Lappin. In this presentation, Graham explains the importance of mAb-target engagement and rate of target turnover in assessing whether or not anContinue Reading
Date Posted: December 23, 2011
Summary: A paper on a presentation by Dr Mark Seymour on the use of AMS as a frontline technique in bioanalytical detection has been published in the December 2011 issue of Bioanalysis. The paper was presented at the Reid Bioanalytical Forum in July earleir this year. The full paper can be downloaded from the FutureContinue Reading
Date Posted: April 7, 2011
Anti-Infective Microdose Study Aimed at MRSA. Microdosing studies were conducted to assess human PK, oral bioavailability, pseudo?mass balance and distribution in skin blisters.
Date Posted: June 22, 2010
Celgene Absolute Bioavailability Data – ASCPT 2010 Poster
Publications
Xceleron RSS Feed